Updated July 30, 2026
If you live in Florida and are researching compounded GLP-1 medications, this page is meant to save you some digging. It explains how access works in the state, what Florida law actually says about telehealth prescribing and about the pharmacies that compound and ship medication, what compounded semaglutide and tirzepatide cost, and how several providers serving Florida compare on published cash prices. Everything here is drawn from public sources, with links, so you can check our work.
One disclosure up front: this site is operated by Gentle Health, a telehealth provider offering compounded GLP-1 treatment for weight management. Gentle Health appears in the comparison table below on the same terms as every other provider listed.
How compounded GLP-1 access works in Florida
Florida is one of the clearer states in the country on telehealth. Its telehealth statute, section 456.47, Florida Statutes, says a telehealth provider “may use telehealth to perform a patient evaluation,” and that if that evaluation is sufficient to diagnose and treat the patient, no separate in-person examination is required first. The same statute holds telehealth to the prevailing professional standard of practice that applies to in-person care, so the bar for the medicine itself does not move.
Here is what that looks like in practice for a Gentle Health patient in Florida:
- Complete a medical intake. You answer questions about your health history, current medications, and goals. This is the information a physician needs to decide whether a GLP-1 is appropriate for you.
- Physician review. Your intake is reviewed by James Simmons, MD, who holds a Florida medical license (license ME183513, state board record). Dr. Simmons evaluates every Florida patient individually; not everyone who applies is approved.
- Prescription and fulfillment. If Dr. Simmons determines treatment is appropriate, the prescription is sent to a licensed compounding pharmacy, and the medication ships to your home anywhere in Florida, from Pensacola to Key West.
- Ongoing care. Dosing is adjusted over time based on how you respond, and you can reach Dr. Simmons with questions between check-ins.
Worth knowing as you compare providers: Florida also runs a separate out-of-state telehealth provider registration under s. 456.47(4), which lets a professional licensed elsewhere serve Florida patients by telehealth after registering with the state. Registrants appear on a public Department of Health list, may not open a Florida office, and may not see Florida patients in person. That framework is how some national telehealth companies operate here. It is not what Gentle Health relies on: Dr. Simmons holds a full Florida license, which you can verify at the link above. Either way, the useful habit is the same, look the prescriber up before you sign up.
Florida rules worth knowing
Two bodies of Florida law shape how compounded GLP-1s reach patients here: the telehealth statute that governs prescribers, and the pharmacy chapter that governs the pharmacies compounding and shipping the medication.
Telehealth prescribing. A few points from s. 456.47 worth knowing:
- A telehealth evaluation can stand on its own. If it is “sufficient to diagnose and treat the patient,” the provider is not required to conduct a physical examination before treating by telehealth.
- The standard of care is the same as in person. There is no separate, looser standard for online visits.
- The statute’s tightest prescribing restriction applies to Schedule II controlled substances, which generally cannot be prescribed by telehealth outside settings such as psychiatric treatment, hospital inpatient care, hospice, or nursing homes. GLP-1 medications are not controlled substances, so that restriction does not apply to them.
- The law deems care to occur where the patient is located. A Florida patient is owed Florida’s standards regardless of where the prescriber sits, and Florida venue rules apply if something goes wrong.
The pharmacy side. Florida regulates pharmacies under chapter 465, Florida Statutes, and the rules follow the medication across state lines. An out-of-state pharmacy shipping prescriptions to Florida patients must register as a nonresident pharmacy under s. 465.0156, and if it ships compounded sterile products, injectables, it must also hold a nonresident sterile compounding permit under s. 465.0158. The telehealth statute reinforces this: registered telehealth pharmacists may only dispense to Florida patients through Florida-permitted or Florida-registered pharmacies.
The federal backdrop. Under Section 503A of the Food, Drug and Cosmetic Act, pharmacies generally may not compound “drug products that are essentially copies of a commercially available drug product.” During the national shortages of semaglutide and tirzepatide products, those drugs were not considered commercially available, which opened the door to widespread compounding. The FDA has since declared both shortages resolved, semaglutide in a February 21, 2025 statement, and its enforcement grace periods for compounders ended in spring 2025. What remains on the market in 2026 is compounding for an individual patient under a valid prescription, where the compounded product is not an essential copy of a manufactured one. The ground can still shift: in April 2026, the FDA proposed removing semaglutide and tirzepatide from the list of bulk substances that 503B outsourcing facilities may use (Pharmacy Times coverage), a change that, if finalized, would further narrow how compounded GLP-1s can be made.
Florida’s legislature has been circling this too. In the 2026 session, Senate Bill 860 would have barred the sale or distribution of compounded medications for, in the bill’s words, “weight loss” unless the seller documented that the active ingredient matched the FDA-approved version and came from a recently inspected facility, with fines per prescription. The bill died in its first committee in March 2026 without a vote. It did not become law, but it is a fair signal that Florida lawmakers are watching this market, and that the documentation practices it described, ingredient sourcing, testing, licensure, are the right things to ask any provider about now.
None of this is a reason to avoid asking questions. It is a reason to ask more of them: who is prescribing, what pharmacy is compounding, and whether both are licensed or registered for Florida.
Compounded semaglutide in Florida
Semaglutide is a GLP-1 receptor agonist. It works by mimicking a hormone your body already makes, one that signals fullness, slows how quickly your stomach empties, and helps regulate blood sugar. The practical effect most patients describe is that food quiets down: smaller portions satisfy, and the constant background negotiation with appetite eases.
Compounded semaglutide is prepared by a licensed compounding pharmacy for an individual patient, based on a prescription. It is not FDA-approved, which is a factual difference worth understanding, not a footnote: compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality before dispensing. Oversight comes instead from state pharmacy regulators, Florida’s permit requirements above being one example, and from the prescribing physician’s judgment about the individual patient. That is exactly why the questions about licensure and sourcing matter.
Gentle Health offers compounded semaglutide to Florida patients in two forms, at flat cash prices:
- Oral semaglutide: $112 per month. Taken daily, no needles involved.
- Injectable semaglutide: $135 per month. A once-weekly subcutaneous injection with a small needle.
Both prices are cash-pay and flat across dose levels, so the price does not climb as your dose is adjusted. Treatment is subject to medical evaluation by Dr. Simmons, and continuing care is included rather than billed separately.
Compounded tirzepatide in Florida
Tirzepatide works on two hormone receptors rather than one: GLP-1 and GIP. Like semaglutide, it is prescribed for weight management alongside changes to eating and activity; the dual mechanism is the main pharmacological distinction between the two medications. Which one is appropriate for a given patient, if either, is a clinical decision, not a menu choice, and it depends on health history, other medications, and how a patient responds over time.
Compounded tirzepatide, like compounded semaglutide, is prepared for an individual patient by a licensed compounding pharmacy and is not FDA-approved.
Gentle Health offers compounded injectable tirzepatide to Florida patients at $169 per month, cash-pay, flat across dose levels, once weekly. As with semaglutide, the evaluation, prescription decision, and ongoing dose adjustments are handled by James Simmons, MD.
Provider options in Florida: comparison table
Methodology: rows are ordered alphabetically; prices were taken only from each provider’s public web pages on 2026-07-30, and where a provider does not publish a price we say “See site” rather than guessing. Gentle Health operates this site and is listed on the same terms as everyone else. We do not rank providers.
| Provider | Care model | Compounded semaglutide (cash/mo) | Compounded tirzepatide (cash/mo) | Serves Florida | Insurance | Source |
|---|---|---|---|---|---|---|
| Eden | Telehealth; medication price plus separate membership ($39 first month, then $99/mo) | $99 + membership | $199 + membership | See site | Not required; HSA/FSA eligible | eden.health (verified 2026-07-30) |
| Gentle Health (operates this site) | Telehealth; care by James Simmons, MD; flat pricing, no separate membership fee | $112 oral / $135 injectable | $169 | Yes | No insurance; cash-pay only | gentlehealth.com (verified 2026-07-30) |
| Medi-Weightloss | In-person clinics; Tampa-headquartered chain with Florida locations; program visits, some insurance accepted | $99 first month (offer); ongoing See site | $199 first month (offer); ongoing See site | Yes (Florida clinic locations) | Accepts many major plans for program visits | mediweightloss.com (verified 2026-07-30) |
| Mochi Health | Telehealth; medication price plus $79/mo membership | $99 + membership | $199 + membership | Yes (serves all US states per its FAQ) | See site | joinmochi.com (verified 2026-07-30) |
| Noom Med | Telehealth; low-dose program bundling care and medication, billed $537 per 12 weeks after intro | From $179 (low-dose program) | See site | See site (Noom’s page notes it is not available in all 50 states) | Not required; FSA/HSA eligible | noom.com (verified 2026-07-30) |
| Remedy Meds | Telehealth; subscription plans, month-to-month | See site | See site | See site | Not required; HSA/FSA accepted | remedymeds.com (verified 2026-07-30) |
A few reading notes. Headline medication prices and total monthly cost are not the same thing: where a provider charges a separate membership fee, your real monthly outlay is the sum of the two lines. First-month offers are also common in this market, Florida included, so it is worth checking what month four costs, not just month one. And every provider on this list requires a medical evaluation; a price is only relevant if a licensed prescriber determines treatment is appropriate for you.
Frequently asked questions: compounded GLP-1 in Florida
Is compounded semaglutide legal in Florida? Compounding for an individual patient under a valid prescription is legal under federal law (Section 503A) and Florida law when the pharmacy holds the right Florida permits and the compounded product is not an essential copy of a commercially available drug. Since the FDA declared the semaglutide and tirzepatide shortages resolved in 2025, compounding copies of the approved products is no longer permitted, so what remains available are individualized formulations prescribed for specific patients. A Florida bill that would have restricted compounded GLP-1s further, SB 860, died in committee in March 2026, but the area remains under active regulatory attention.
Do I need an in-person doctor visit to get a GLP-1 prescription in Florida? No. Section 456.47, Florida Statutes allows a telehealth provider to perform the patient evaluation by telehealth, and if that evaluation is sufficient to diagnose and treat, no prior physical examination is required. The telehealth restriction on Schedule II controlled substances does not apply because GLP-1s are not controlled substances.
Who prescribes for Gentle Health patients in Florida? James Simmons, MD, who holds a Florida medical license (ME183513). You can confirm the license through the Florida Department of Health’s license verification search. Every prescription decision at Gentle Health is made by Dr. Simmons based on an individual medical evaluation.
How can I check whether an online provider is allowed to treat patients in Florida? Two lookups cover it. For the prescriber: search the Florida DOH license verification site for a Florida license, or check the state’s out-of-state telehealth registrant list if the clinician is registered rather than licensed here. For the pharmacy: it should hold a Florida pharmacy permit or, if out of state, a nonresident pharmacy registration, plus a nonresident sterile compounding permit if it ships injectables. A provider should be able to tell you plainly which pharmacy fills its Florida prescriptions.
Does insurance cover compounded GLP-1s in Florida? Generally, no. Insurance plans typically do not cover compounded medications, and most telehealth providers in this market, Gentle Health included, are cash-pay. Some accept HSA or FSA funds, and some in-person clinics bill insurance for program visits even though the compounded medication itself is cash-pay; check the individual provider’s site.
How does the medication get to me? After a prescription is issued, a licensed compounding pharmacy prepares your medication and ships it to your address in Florida. Out-of-state pharmacies shipping into Florida must be registered with the state under s. 465.0156, with an additional sterile compounding permit for injectables under s. 465.0158. Shipments are packaged for temperature control where the formulation requires it, which matters in a Florida summer.
Can I get compounded GLP-1 treatment anywhere in Florida, or only in the big metros? Anywhere in the state. Because the model is telehealth plus home delivery, a patient in Marianna, Okeechobee, or Palatka has the same access as a patient in Miami, Orlando, or Tampa. That is arguably where telehealth earns its keep: Florida’s population is spread across long distances, and obesity medicine capacity is concentrated in a handful of metro areas.
Reviewed by James Simmons, MD Last updated: August 6, 2026
Compounded medications are not FDA-approved. Treatment subject to medical evaluation.